Article
What's the average closing rate for U.S. dermatology practices? Mr. Atwood suspects it could be as low as 10 to 20 percent in some practices.
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring
Phase 3 Trial Supports Roflumilast for Pediatric AD